Immunexpress Inc.’s Post

Last week, Immunexpress Inc. presented at WiSE Pathology Laboratory and Peter MacCallum Cancer Centre to an audience of scientists and clinicians. Immunexpress’s Jane (Markley) Papadaki (VP of Commercial Operations) and Richard Brandon (Chief Scientific Officer) discussed: • SeptiCyte RAPID’s applicability for early sepsis identification. • Challenges of diagnosing sepsis in immunocompromised or cancer patients. Thank you to Jane, Richard, and all attendees for their commitment to improving patient outcomes. Learn more about SeptiCyte RAPID → https://lnkd.in/gkZneHyz #abacusdx #immunexpress #sepsis #septicyte